Who invested in DTRM Biopharma?
DTRM Biopharma's investors include Green Pine Capital.
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$60Mraised across 1 round since 2018, from 1 source
DTRM Biopharma's investors include Green Pine Capital.
DTRM Biopharma has raised $60M across 1 round since 2018.
DTRM Biopharma's most recent round was a Series A of $60M in Jan 2018.
Its most recent round, $60M in Jan 2018, is also its largest on record.
DTRM Biopharma's first round on record, in Jan 2018, was backed by Green Pine Capital.
DTRM Biopharma's latest named round is a Series A, in Jan 2018.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.